Wall Street brokerages expect Nutrisystem (NASDAQ:NTRI) to post earnings of $0.07 per share for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Nutrisystem’s earnings, with the highest EPS estimate coming in at $0.08 and the lowest estimate coming in at $0.06. Nutrisystem posted earnings per share of $0.25 in the same quarter last year, which would suggest a negative year-over-year growth rate of 72%. The company is expected to report its next earnings results after the market closes on Monday, April 30th.
On average, analysts expect that Nutrisystem will report full-year earnings of $2.05 per share for the current fiscal year, with EPS estimates ranging from $2.02 to $2.09. For the next year, analysts forecast that the business will post earnings of $2.37 per share, with EPS estimates ranging from $2.32 to $2.41. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that follow Nutrisystem.
Nutrisystem (NASDAQ:NTRI) last announced its quarterly earnings data on Monday, February 26th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.40 by $0.02. Nutrisystem had a net margin of 8.30% and a return on equity of 48.69%. The business had revenue of $131.20 million during the quarter, compared to the consensus estimate of $128.75 million. During the same period in the previous year, the business earned $0.29 earnings per share. The company’s revenue was up 20.5% on a year-over-year basis.
Several research analysts have commented on the stock. Zacks Investment Research upgraded shares of Nutrisystem from a “hold” rating to a “buy” rating and set a $58.00 price objective for the company in a research report on Tuesday, December 19th. BidaskClub downgraded shares of Nutrisystem from a “hold” rating to a “sell” rating in a research report on Tuesday, January 23rd. B. Riley set a $52.00 price objective on shares of Nutrisystem and gave the company a “buy” rating in a research report on Thursday, February 22nd. Citigroup lowered their price objective on shares of Nutrisystem from $67.00 to $39.00 and set a “buy” rating for the company in a research report on Monday, March 5th. Finally, Argus downgraded shares of Nutrisystem from a “buy” rating to a “hold” rating in a research report on Tuesday, March 20th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. Nutrisystem has an average rating of “Hold” and an average price target of $57.00.
NTRI traded down $0.05 during trading on Thursday, hitting $28.05. 1,091,779 shares of the stock traded hands, compared to its average volume of 770,811. Nutrisystem has a twelve month low of $26.06 and a twelve month high of $67.95. The company has a market cap of $838.39, a P/E ratio of 14.31, a P/E/G ratio of 0.82 and a beta of 1.11.
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 19th. Investors of record on Thursday, March 8th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 3.57%. This is an increase from Nutrisystem’s previous quarterly dividend of $0.18. The ex-dividend date was Wednesday, March 7th. Nutrisystem’s dividend payout ratio is presently 51.02%.
In related news, insider Dawn M. Zier sold 30,825 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $40.37, for a total value of $1,244,405.25. Following the completion of the sale, the insider now directly owns 221,013 shares in the company, valued at $8,922,294.81. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Keira Krausz sold 5,000 shares of the stock in a transaction on Thursday, January 11th. The shares were sold at an average price of $50.96, for a total value of $254,800.00. Following the completion of the sale, the insider now owns 75,463 shares of the company’s stock, valued at $3,845,594.48. The disclosure for this sale can be found here. Insiders sold 65,831 shares of company stock valued at $3,070,319 over the last 90 days. 2.40% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the business. MetLife Investment Advisors LLC bought a new stake in Nutrisystem during the fourth quarter valued at $750,000. Gotham Asset Management LLC boosted its position in Nutrisystem by 17.3% during the fourth quarter. Gotham Asset Management LLC now owns 319,747 shares of the company’s stock valued at $16,819,000 after acquiring an additional 47,073 shares during the last quarter. Park West Asset Management LLC boosted its position in Nutrisystem by 207.4% during the fourth quarter. Park West Asset Management LLC now owns 415,000 shares of the company’s stock valued at $21,829,000 after acquiring an additional 280,000 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its position in Nutrisystem by 31.5% during the fourth quarter. Municipal Employees Retirement System of Michigan now owns 14,750 shares of the company’s stock valued at $776,000 after acquiring an additional 3,530 shares during the last quarter. Finally, Teachers Advisors LLC boosted its position in Nutrisystem by 2.7% during the fourth quarter. Teachers Advisors LLC now owns 462,679 shares of the company’s stock valued at $24,337,000 after acquiring an additional 12,322 shares during the last quarter.
WARNING: “Zacks: Analysts Expect Nutrisystem (NTRI) Will Announce Earnings of $0.07 Per Share” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/08/zacks-analysts-expect-nutrisystem-ntri-will-announce-earnings-of-0-07-per-share.html.
Nutrisystem Company Profile
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.
Get a free copy of the Zacks research report on Nutrisystem (NTRI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nutrisystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem and related companies with MarketBeat.com's FREE daily email newsletter.